Preliminary financial results for the 2022 fiscal year
|
EQS-Ad-hoc: Symrise AG / Key word(s): Preliminary Results
According to preliminary calculations, the key figures for the 2022 fiscal year deviate from the expectations of the capital market mainly due to an impairment loss of € 126 million related to the interest in the Swedish company Swedencare AB. These capital market expectations are based on the latest consensus estimates by financial analysts, published by Vara Research on January 20, 2023.
For this reason, Symrise is publishing the following preliminary financial key figures for the 2022 fiscal year already today:
The 2022 annual report will be published on March 8, 2023. Forward-looking statements This ad-hoc statement may contain forward-looking statements based on current assumptions and forecasts made by Symrise AG. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Symrise's public reports which are available at www.symrise.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. Contact: Tobias Erfurth, Investor Relations
20-Jan-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Symrise AG |
| Mühlenfeldstraße 1 | |
| 37603 Holzminden | |
| Germany | |
| Phone: | +49 (0)5531 90 0 |
| E-mail: | ir@symrise.com |
| Internet: | www.symrise.com |
| ISIN: | DE000SYM9999, DE000SYM7787, DE000SYM7704 |
| WKN: | SYM999 |
| Indices: | DAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1540563 |
| End of Announcement | EQS News Service |
|
|
1540563 20-Jan-2023 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.